[Translated article] Moderate to Severe Psoriasis in Pediatric and Young Patients: The BIOBADADERM Registry Experience

• Main Authors: L.M. Nieto Benito (Author), G. Carretero (Author), R. Rivera-Díaz (Author), J.M. Carrascosa (Author), E. Daudén (Author), P. de la Cueva (Author), A. Sahuquillo-Torralba (Author), E. Herrera-Acosta (Author), O. Baniandrés-Rodríguez (Author), J.L. Lopez-Estebaranz (Author), I. Belinchón (Author), J. Riera-Monroig (Author), M. Ferrán (Author), F.J. Gómez-García (Author), A. Mateu (Author), L. Rodríguez (Author), J. Vilar-Alejo (Author), C. García-Donoso (Author), F. Ballescá (Author), L.-M. Velasco (Author), R. Botella-Estrada (Author), E. Herrera-Ceballos (Author), D.P. Ruiz-Genao (Author), M.A. Descalzo (Author), I. García-Doval (Author)
• Format: Book
• Published: Elsevier, 2022-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Childhood-onset psoriasis generally follows an indolent course but patients with moderate or severe disease may require systemic treatment. The aim of this study was to determine the relative proportion of children and young people aged up to 21 years with moderate to severe psoriasis in the BIOBADA...